Tomohiro Terada Selected Research

Interstitial Lung Diseases (Interstitial Lung Disease)

1/2022	Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis.
7/2013	Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohiro Terada Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 11/2008
7	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 10/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2013 - 04/2010
4	Neutropenia 10/2018 - 04/2009
4	Neoplasm Metastasis (Metastasis) 07/2013 - 04/2010
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 04/2008
3	Infections 01/2022 - 01/2010
3	Hemorrhage 11/2021 - 09/2017
3	Exanthema (Rash) 09/2021 - 07/2013
3	Cholestasis 02/2020 - 07/2008
3	Atrial Fibrillation 01/2019 - 09/2017
3	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2012
3	Fatigue 06/2017 - 09/2012
2	Aspergillosis 08/2022 - 01/2022
2	Vomiting 08/2022 - 01/2019
2	Nausea 08/2022 - 01/2019
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 08/2015
2	Leukopenia 01/2022 - 06/2004
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2013
2	Lymphoma (Lymphomas) 12/2021 - 01/2019
2	Endophthalmitis (Ophthalmia) 11/2021 - 01/2021
2	Thrombosis (Thrombus) 11/2021 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 05/2006
2	Pathologic Processes 01/2019 - 06/2015
2	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 11/2008
2	Stomatitis 10/2018 - 07/2013
2	Hypertension (High Blood Pressure) 07/2018 - 01/2012
2	Hyperuricemia 01/2017 - 01/2015
2	Thrombocytopenia (Thrombopenia) 08/2015 - 01/2012
2	Stomach Neoplasms (Stomach Cancer) 01/2014 - 12/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2010 - 05/2010
1	Respiratory Insufficiency (Respiratory Failure) 08/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2022
1	Major Depressive Disorder (Major Depressive Disorders) 05/2022
1	COVID-19 01/2022
1	Retinal Detachment (Retinal Detachments) 11/2021
1	Hand-Foot Syndrome 09/2021
1	Acne Vulgaris 09/2021
1	Erythema Multiforme 09/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 02/2020
1	Atherosclerosis 02/2020
1	Chemical and Drug Induced Liver Injury 02/2020
1	Muscular Diseases (Myopathy) 02/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2020
1	Dyslipidemias (Dyslipidemia) 02/2020
1	Myocardial Infarction 01/2020

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2016 - 07/2006
5	Sorafenib (BAY 43-9006)FDA Link 09/2021 - 10/2010
5	Phospholipids (Phosphatides)FDA LinkGeneric 02/2020 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2006
5	Sunitinib (Sutent)FDA Link 01/2016 - 01/2012
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2013 - 04/2010
5	Messenger RNA (mRNA)IBA 01/2010 - 12/2005
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2010
4	ErbB Receptors (EGF Receptor)IBA 10/2018 - 04/2010
3	Bile Acids and Salts (Bile Acids)IBA 01/2019 - 07/2008
3	apixabanIBA 01/2019 - 09/2017
3	OSI-420IBA 09/2011 - 05/2010
2	Itraconazole (Sporanox)FDA LinkGeneric 08/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 04/2010
2	DiureticsIBA 01/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2021
2	Silicone OilsIBA 11/2021 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 10/2018 - 01/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2017 - 04/2015
2	Febuxostat FDA Link 01/2017 - 01/2015
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2016 - 04/2009
2	Organic Anion TransportersIBA 04/2009 - 07/2008
2	CationsIBA 11/2008 - 04/2008
2	Peptide Transporter 1IBA 11/2006 - 12/2005
1	TabletsIBA 08/2022
1	SolutionsIBA 08/2022
1	BenzodiazepinesIBA 05/2022
1	suvorexantIBA 05/2022
1	Eszopiclone (Lunesta)FDA Link 05/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	remdesivirIBA 01/2022
1	ProdrugsIBA 01/2022
1	Valganciclovir FDA Link 01/2022
1	GS-441524IBA 01/2022
1	NucleosidesIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 12/2021
1	Vancomycin FDA LinkGeneric 11/2021
1	Ceftazidime (Fortum)FDA LinkGeneric 11/2021
1	edoxabanIBA 11/2021
1	NivolumabIBA 09/2021
1	lenvatinibIBA 01/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2020
1	Clopidogrel (Plavix)FDA Link 01/2020

Therapy/Procedure

12	Therapeutics 01/2022 - 10/2010
10	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
2	Lung Transplantation 08/2022 - 01/2022
2	Renal Dialysis (Hemodialysis) 10/2010 - 05/2010
1	Intravitreal Injections 11/2021
1	Off-Label Use 11/2021
1	Nebulizers and Vaporizers (Inhaler) 08/2021
1	Stents 01/2020